A functional allelic variant of the FGF23 gene is associated with renal phosphate leak in calcium nephrolithiasis

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages

  Rendina, Domenico ^a   Esposito, Teresa ^b   Mossetti, Giuseppe ^a   De Filippo, Gianpaolo ^a,c   Gianfrancesco, Fernando ^b   Perfetti, Anna ^a   Magliocca, Sara ^b   Formisano, Pietro ^a   Prié, Dominique ^d   Strazzullo, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATE;

ADULT; ALLELE; ARTICLE; CALCIUM NEPHROLITHIASIS; CONTROLLED STUDY; FGF23 GENE; GENE; GENE ACTIVATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIA NEPHROLITHIASIS; IN VITRO STUDY; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; PATHOGENESIS; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION;

ADULT; ALLELES; CALCIUM; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIA; KIDNEY; MALE; MIDDLE AGED; NEPHROLITHIASIS; PHOSPHATES;

EID: 84860762505     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1528     Document Type: Article

References (20)

1. Prié D, Friedlander G 2010 Genetic disorders of renal phosphate transport. N Engl J Med 362:2399-2409
2. Karim Z, Gérard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prié D 2008 NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359:1128-1135
3. Prié D, Huart V, Bakouh N, Planelles G, Dellis O, Gérard B, Hulin P, Benqué-Blanchet F, Silve C, Grandchamp B, Friedlander G 2002 Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347:983-991
4. Fukumoto S, Yamashita T 2007 FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23. Bone 40:1190-1195
5. Rendina D, Mossetti G, De Filippo G, Cioffi M, Strazzullo P 2006 Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak. J Clin Endocrinol Metab 91:959-963
6. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T 2008 Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235-1239
7. Rendina D, De Filippo G, Strazzullo P 2008 NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359:2616-2617
8. Walton RJ, Bijvoet OL 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309-310
9. Elston RC, Forthofer R 1977 Testing for Hardy-Weinberg equilibrium in small samples. Biometrics 33:536-542
10. Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H, Fujita T, Kuroki R, Yamashita T, Fukumoto S, Shimada T 2008 Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23:1509-1518
11. Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M 2011 Regulation of serum 1, 25 (OH) 2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol 301:F371-F377
12. Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M 2009 FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297:F282-F291
13. Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J 2002 Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30:91-98
14. Shaul YD, Seger R 2007 The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773:1213-1226
15. Schiavi SC, Kumar R 2004 The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 65:1-14
16. White KE, Larsson TE, Econs MJ 2006 The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27:221-241
17. Farrow EG, Davis SI, Summers LJ, White KE 2009 Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20:955-960
18. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B 1994 HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57
19. Shimizu H, Bolati D, Adijiang A, Adelibieke Y, Muteliefu G, Enomoto A, Higashiyama Y, Higuchi Y, Nishijima F, Niwa T 2011 Indoxyl sulfate downregulates renal expression of Klotho through production of ROS and activation of nuclear factor-κB. Am J Nephrol 33:319-324
20. Frishberg Y, Ito N, Rinat C, Yamazaki Y, Feinstein S, Urakawa I, Navon-Elkan P, Becker-Cohen R, Yamashita T, Araya K, Igarashi T, Fujita T, Fukumoto S 2007 Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 22:235-242